• $20M Gift to Dana-Farber Will Establish Fund for Metastatic Breast Cancer Research
  • Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial
  • Obesity Reprograms Immune Cells in Mammary Tissues to Promote Tumor Development, Study Says
  • Puma Applies to FDA to Extend Nerlynx’s Use to HER2-Positive Metastatic Breast Cancer
  • CHMP Recommends Tecentriq-Abraxane Combination to Treat Some Triple-negative Breast Cancers in Europe
  • Survival Is All About the Money
  • Fujifilm Bus Hits the Road to Offer Breast Cancer Screenings and Promote Early Diagnosis
  • Breast Cancer Index Identifies Patients Who Will Benefit From Extended Endocrine Therapy, Data Shows
  • European Commission Approves Talzenna to Treat Some Breast Cancers
  • Tecentriq-Abraxane Combo Prolonging Survival in TNBC Patients, Phase 3 Trial Data Show
  • Anti-Diarrheal Medicines Improve Tolerability of Nerlynx in Breast Cancer Patients
  • Kisqali-Endocrine Therapy Combo Increases Overall Survival In Hormone Receptor-Positive Breast Cancer Patients, Study Shows